Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert. Abhishek Wani / Friday, February 28, 2025 0 116 Article rating: 5.0 Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert. Read more